These experiments revealed no differences in the growth kinetics/sizes of WT versus Sharpin-deficient tumors, indicating that lifting restraint on tumor cell sensitivity to RIPK1-dependent cell death only results in accelerated tumor destruction if both T cells and TNF are present, echoing the observations of the transplant model. The gene discussed is SHARPIN; the disease is neoplasm.